A randomized controlled trial comparing the first-line eradication rate using vonoprazan or PPI for Helicobacter pylori infectious gastritis.
Not Applicable
- Conditions
- Helicobacter pylori infectious gastritis.
- Registration Number
- JPRN-UMIN000021148
- Lead Sponsor
- nagano red cross hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
80 years old or older. A patient has severe organ dysfunction. A patient having allergy of the study drug. A patient that it was judged that eradication was inappropriate on the medical examination of the medical attendant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rates and adverse events. We evaluate the eradication in all cases using C13-urea breath test (UBT) at eight weeks after completion of the therapy. We perform a questionnaire to a patient, and we evaluate presence of a diarrhea, loose stool, exanthem, taste disorder, fever, other physical condition defectiveness about the side effect.
- Secondary Outcome Measures
Name Time Method Taking medicine compliance.